NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into ROSALIND®, OnRamp’s cloud-based analysis platform that facilitates data visualization, exploration and collaboration. NanoString will support ROSALIND as a preferred analysis solution for nCounter data and make it broadly available to users of the nCounter Analysis System.
Search
Recent Posts
See AllIterative Scopes to Present Three Abstracts on Artificial Intelligence Applications for GI Endoscopy
Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that its artificial intelligence platforms will be featured in three abstract presentations at the
A study by Luna confirms pelvic floor patients prefer "in-person" to "virtual-only" for at home care
Luna, the leading provider of in-home physical therapy, has unveiled a new patient study, which casts doubt on virtual-only care for pelvic floor disorders. In the study, 97% of patients with pelvic f
TripleBlind, creator of the most complete and scalable solution for privacy enhancing computation, announces Craig Gentry as the new Chief Technology Officer. Craig will lead TripleBlind’s technology
